ChrysCapital buys controlling stake in Novartis India
ChrysCapital acquires controlling stake in Novartis India and appoints a new CEO. This marks a major shift in ownership and leadership. The deal underscores strong investor interest in Indian pharma assets. Controlling stake acquisition could lead to strategic realignment.
📊 STOCKS: $NOVARTIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #M&A
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.